Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Therapeutic effects of nonerythropoietic erythropoietin analog ARA290 in experimental autoimmune encephalomyelitis rat.
Risk of multiple sclerosis after optic neuritis in patients with normal baseline brain MRI.
Diazoxide Attenuates Autoimmune Encephalomyelitis and Modulates Lymphocyte Proliferation and Dendritic Cell Functionality.
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities.
Chronic cerebrospinal venous insufficiency: pitfalls and perils of sonographic assessment.
Early P2X7R-related astrogliosis in autoimmune encephalomyelitis.
Paucity of natural killer and cytotoxic T cells in human neuromyelitis optica lesions.
Ocular side effects of drugs used in the treatment of multiple sclerosis.
Viral exposures and MS outcome in a prospective cohort of children with acquired demyelination.
Reproducibility of T2 * mapping in the human cerebral cortex in vivo at 7 tesla MRI.
VIP and PACAP: Neuropeptide modulators of CNS inflammation, injury, and repair.
Axon-glia interaction and membrane traffic in myelin formation.
Towards a Quantitative OCT Image Analysis.
Magnetic resonance monitoring of lesion evolution in multiple sclerosis.
Sphingosine-1 phosphate and central nervous system.
Diagnostic tools for evaluating the impact of Focal Axonal Swellings arising in neurodegenerative diseases and/or traumatic brain injury.
PDE4B as a microglia target to reduce neuroinflammation.
Hyperinsulinemia in newly diagnosed patients with multiple sclerosis.
Krabbe disease: involvement of connexin43 in the apoptotic effects of sphingolipid psychosine on mouse oligodendrocyte precursors.
Managing patients with neurologic disorders who participate in sports activities.
Microanatomy and histological features of central myelin in the root exit zone of facial nerve.
Increased HLA-E expression in white matter lesions in multiple sclerosis.
Four Promoters of IRF5 Respond Distinctly to Stimuli and are Affected by Autoimmune-Risk Polymorphisms.
[Pegylated interferon beta 1a : A new therapy option for treatment of relapsing-remitting multiple sclerosis].
The effect of exercise training on fitness in multiple sclerosis: A meta-analysis.

Pages